Physiomics Share News (PYC)

UK WINNERS & LOSERS: Domino's Pizza Jumps, Food Retailers Slip

Physiomics Shares Jump On New Contract Win

Physiomics bounces on first commercial contract

Computer-aided biology provider Physiomics has signed a first contract to supply its Virtual Tumour service to a biotech company. The Aim company said it will receive an up-front fee to provide access to its technology as well as ongoing service fees as the project progresses. This is the Oxford-

Physiomics reports fall in operating loss, rise in turnover

UK biology company Physiomics said operating loss dropped 6.3 per cent in the last half of 2012 as the group signed on new clients and progressed in research and development of products. Operating loss came to £307,685, compared to £328,674 for the same period a year ago, as turnover increased 52.9

Physiomics secures 4.0m pound flexible financing option

UK-based systems biology company Physiomics has entered into a 4.0m pound standby equity distribution agreement with YA Global Master SPV, an investment fund managed by Yorkville Advisors. The agreement is primarily intended to strengthen the company's position for future mergers and acquisitions n

Small caps round-up: Staffline, Physiomics, Lonrho, Digital Learning

Staffline Group, a recruitment organisation focused on the food processing, manufacturing, e-retail and logistics sectors, has acquired certain assets from DKM Driving, which specialises in the provision of temporary drivers to a number of corporate customers in the Midlands area. The acquisition is

Small caps round-up; Cyan, Victoria, Physiomics ...

Semiconductor company Cyan Holdings has reported that 16 firms have submitted proposals for the tender relating to the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading, and that five of these are based on the company's Cylec technology. TNEB is one of the largest electricity distributors

Small caps round-up: K3, Densitron, Innovation...

Software firm K3 Business Technology Group has received a number of indicative proposals at levels materially higher than the current share price, which it will explore these under a formal sale process and is now consequently in an offer period. Shares in the firm leapt 21.75 percent to 187.50p.

London close: Good gains as FTSE 100 rallies

Stocks rediscovered their earlier buoyancy to finish with strong gains as hopes of a resolution of the euro crisis attracted buyers. Today's big mover, Cairn Energy, fell sharply after reporting disappointing results from its drilling campaign offshore Greenland, with one well coming up dry and ano

London midday: Eurozone worries resurface

This morning's bright start seems a distant memory now, with shares firmly in the red as worries over the Eurozone situation take centre stage again. Today's big mover, Cairn Energy is sharply lower after reporting disappointing results from its offshore drilling campaign offshore Greenland, with o

Physiomics wins prostate cancer drug deal

Physiomics, which makes computer models that simulate biological cell behaviour, has agreed to collaborate over development of a prostate cancer drug. The agreement with ValiPharam Limited will see Physiomics help test how the drug "VAL201" performs in combating tumour growth. In essence Physionom

London midday: FTSE 100 stable after calm start

Shares are holding onto their gains today amid much calmer trading than the volatility seen last week. In company news, international recruitment firm Michael Page is sharply lower. It made a flying start to 2011 but said profit growth in the banking sector has tailed off in the second half of the

Cancer results boost Sareum

Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method of controlling a cancer cells' response to DNA damage. The candidate, when orally dosed, reduces cancer growth rates compared to treatment with the

Physiomics issues shares at discount

Penny stock Physiomics fell sharply Wednesday, giving back some of last week's heavy gains, after announcing a share issue at a discount to the prevailing market price. The company has issued 120m shares at a price of 0.5p per share by way of a placing, to raise £0.6m to boost working capital. Fo

Physiomics hits 52-week high on study outcome

The Oxford based systems biology company Physiomics said positive results have been generated in a pre-clinical study into breast cancer based on the company's "Virtual Tumour" model predictions. The directors believe these results provide further validation as to the predictive capability of the